November 2026
Oral Syrups

Advanced Formulations for Allergy Management

Bilastine + Montelukast Syrup

Bilastine 10 mg + Montelukast 4 mg per 5 ml

Bilastine and Montelukast Oral Syrup
1+ Formulations Ready
Custom Pack (60 ml / 100 ml) Pack size options
Antihistamine Therapeutic Class
WHO-GMP Production standard
Campaign Highlights
Combines an antihistamine with a leukotriene receptor antagonist
Used in the management of allergic conditions as prescribed
Supports relief from allergy-associated symptoms
Suitable for prescription-based pharmaceutical product portfolios
Explore More

Linked Manufacturing Capabilities

Explore related manufacturing divisions, dosage forms, and technical resources to support your product launch.

Bilastine and Montelukast Syrup combines an antihistamine with a leukotriene receptor antagonist in an oral dosage form intended for prescription-based allergy management.

Saar Biotech offers pharmaceutical manufacturing solutions for businesses looking to expand their product portfolios. Manufacturing feasibility, formulation development, quality control, packaging, and supply arrangements can be discussed according to the product’s approved specifications and applicable regulatory requirements.

Our focus is on consistent product quality, appropriate manufacturing controls, and reliable pharmaceutical production to support your brand’s requirements.

WHO-GMP Certified Quality

Manufactured under strict ISO 9001:2015 & WHO-GMP compliance with complete analytical reports and batch stability data.

End-to-End Launch Support

Custom packaging, precision labeling, regulatory dossiers, and guaranteed on-time commercial batch dispatch across India.

Product Intelligence

Frequently Asked Questions

Common B2B manufacturing and campaign questions about Bilastine and Montelukast Syrup.

What is Bilastine and Montelukast Syrup used for?
This combination may be prescribed for selected allergic conditions. Bilastine is an antihistamine, while Montelukast blocks leukotriene receptors. Use should follow the approved product information and a healthcare professional’s advice.
What is the strength of this formulation?
The specified formulation contains Bilastine 10 mg and Montelukast 4 mg per 5 ml. The final strength and product specifications should be verified against the approved formulation.
Does Saar Biotech offer third-party manufacturing?
Contact Saar Biotech to discuss manufacturing feasibility, regulatory requirements, batch sizes, packaging options, and commercial terms for this formulation.
Direct Manufacturing Desk Available Now
+91 9357690454

Connect directly with our technical team in Baddi for formulation batch planning and custom MOQs.

Ready to start a manufacturing partnership?

Share your approved composition or product category, dosage form, packing requirement, quantity, and timeline. The Saar team will respond with practical next steps.

Call Us
WhatsApp
Email